The Washington Post on MSN6d
She was diagnosed with Parkinson’s at 27. These were her warning signs.
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
Medindia1h
FDA-Approved Parkinson's Drug Could Alleviate Nicotine Withdrawal Symptoms
Procyclidine shows promise in reducing nicotine withdrawal symptoms, providing a potential new option for smoking cessation ...
Knowridge5d
Research shows major causes of Parkinson’s disease and dementia
Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
Grammy-winning singer, Cleveland native reveals Parkinson’s diagnosis
Marc Cohn, a Cleveland native and a Grammy Award-winning singer best known for his hit "Walking in Memphis," revealed he was ...
Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Early-onset Parkinson’s disease: Woman diagnosed at 27 reveals the warning signs
She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...
The American Journal of Managed Care8d
FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Knowridge7d
New research links kidney failure to Parkinson’s disease
Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...
Purdue Exponent7d
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
Becker's Hospital Review7d
GLP-1 drug fails to slow Parkinson's: Study
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
Compound with neuroprotective properties shows promise for Parkinson's treatment
A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...
Parkinson's Disease Psychosis Market Poised For Significant Growth By 2034, Predicts Delveinsight
DelveInsight's Parkinson's disease Psychosis market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...